Lin, Shih-Ching http://orcid.org/0000-0003-2960-5348
Zhao, Fang R. http://orcid.org/0000-0002-5059-0833
Janova, Hana
Gervais, Adrian http://orcid.org/0000-0002-1083-5787
Rucknagel, Summer
Murray, Kristy O.
Casanova, Jean-Laurent
Diamond, Michael S. http://orcid.org/0000-0002-8791-3165
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01AI073755, R01AI091816, R01AI163029)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01DK122790)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Article History
Received: 12 August 2023
Accepted: 29 August 2023
First Online: 25 September 2023
Competing interests
: M.S.D. is a consultant or advisor for Inbios, Vir Biotechnology, Senda Biosciences, Ocugen, Topspin Therapeutics, Moderna, and Immunome. The Diamond laboratory has received unrelated funding support in sponsored research agreements from Vir Biotechnology, Emergent BioSolutions, and Moderna. J.-L.C. is an inventor on patent application PCT/US2021/042741 submitted by Rockefeller University that covers diagnosis of susceptibility to, and treatment of, viral disease and viral vaccines. The remaining authors declare no competing interests.